0001171843-16-008521.txt : 20160311
0001171843-16-008521.hdr.sgml : 20160311
20160311171523
ACCESSION NUMBER: 0001171843-16-008521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160311
FILED AS OF DATE: 20160311
DATE AS OF CHANGE: 20160311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN CHARLES J.
CENTRAL INDEX KEY: 0001619967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 161501747
MAIL ADDRESS:
STREET 1: C/O XENON PHARMACEUTICALS INC.
STREET 2: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G4W8
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2016-03-11
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001619967
COHEN CHARLES J.
C/O XENON PHARMACEUTICALS INC
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4W8
BRITISH COLUMBIA, CANADA
0
1
0
0
VP, Biology
Stock Option (Right to Buy)
7.49
2016-03-11
4
A
0
25000
0.00
A
2026-03-10
Common Shares
25000
25000
D
Vesting 25% on January 1, 2017, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
/s/ Joanne Smartt, Attorney-in-fact
2016-03-11